Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis

OBJECTIVES: Pulmonary fibrosis is a leading cause of death in systemic sclerosis (SSc). This report examines the differences at baseline and over 12 months between patients with limited versus diffuse cutaneous SSc who participated in the Scleroderma Lung Study. METHODS: SSc patients (64 limited; 94...

詳細記述

保存先:
書誌詳細
主要な著者: Clements, P J, Roth, M D, Elashoff, R, Tashkin, D P, Goldin, J, Silver, R M, Sterz, M, Seibold, J R, Schraufnagel, D, Simms, R W, Bolster, M, Wise, R A, Steen, V, Mayes, M D, Connelly, K, Metersky, M, Furst, D E
フォーマット: Artigo
言語:Inglês
出版事項: BMJ Group 2007
主題:
Extended Report
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2095310/
https://ncbi.nlm.nih.gov/pubmed/17485423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2007.069518
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料